Cargando…

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers

Detalles Bibliográficos
Autores principales: Angelika, Wagner, Erika, Garner-Spitzer, Michael, Kundi, Hannes, Stockinger, Ingrid, Pabinger, Sabine, Eichinger-Hasenauer, Peter, Quehenberger, Oswald, Wagner, Ursula, Wiedermann, Katharina, Grabmeier-Pfistershammer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367206/
https://www.ncbi.nlm.nih.gov/pubmed/36037550
http://dx.doi.org/10.1016/j.thromres.2022.08.005
_version_ 1784765736496922624
author Angelika, Wagner
Erika, Garner-Spitzer
Michael, Kundi
Hannes, Stockinger
Ingrid, Pabinger
Sabine, Eichinger-Hasenauer
Peter, Quehenberger
Oswald, Wagner
Ursula, Wiedermann
Katharina, Grabmeier-Pfistershammer
author_facet Angelika, Wagner
Erika, Garner-Spitzer
Michael, Kundi
Hannes, Stockinger
Ingrid, Pabinger
Sabine, Eichinger-Hasenauer
Peter, Quehenberger
Oswald, Wagner
Ursula, Wiedermann
Katharina, Grabmeier-Pfistershammer
author_sort Angelika, Wagner
collection PubMed
description
format Online
Article
Text
id pubmed-9367206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-93672062022-08-11 Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers Angelika, Wagner Erika, Garner-Spitzer Michael, Kundi Hannes, Stockinger Ingrid, Pabinger Sabine, Eichinger-Hasenauer Peter, Quehenberger Oswald, Wagner Ursula, Wiedermann Katharina, Grabmeier-Pfistershammer Thromb Res Letter to the Editors-in-Chief Published by Elsevier Ltd. 2022-10 2022-08-11 /pmc/articles/PMC9367206/ /pubmed/36037550 http://dx.doi.org/10.1016/j.thromres.2022.08.005 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editors-in-Chief
Angelika, Wagner
Erika, Garner-Spitzer
Michael, Kundi
Hannes, Stockinger
Ingrid, Pabinger
Sabine, Eichinger-Hasenauer
Peter, Quehenberger
Oswald, Wagner
Ursula, Wiedermann
Katharina, Grabmeier-Pfistershammer
Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title_full Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title_fullStr Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title_full_unstemmed Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title_short Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
title_sort preexisting anti-pf4 antibodies are not further triggered upon vaccination with sars-cov-2 vector vaccines in a cohort of 400 health care workers
topic Letter to the Editors-in-Chief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367206/
https://www.ncbi.nlm.nih.gov/pubmed/36037550
http://dx.doi.org/10.1016/j.thromres.2022.08.005
work_keys_str_mv AT angelikawagner preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT erikagarnerspitzer preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT michaelkundi preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT hannesstockinger preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT ingridpabinger preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT sabineeichingerhasenauer preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT peterquehenberger preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT oswaldwagner preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT ursulawiedermann preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers
AT katharinagrabmeierpfistershammer preexistingantipf4antibodiesarenotfurthertriggereduponvaccinationwithsarscov2vectorvaccinesinacohortof400healthcareworkers